MBX Biosciences

MBXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.228 B

$67.82 +1.06%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$87.0M

Loss-making

Shares outstanding

48,160,096

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#77NewAmsterdam PharmaNAMS$3.34B
#78Vicore Pharma Holding ABVCRE$3.33B
#79MBX BiosciencesMBX$3.23B
#80uniQureQURE$3.22B
#81Arcutis BiotherapeuticsARQT$3.18B

Where these numbers come from

Share counts and financials for MBX Biosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.